# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-314871
Filing Date
2013-08-01
Accepted
2013-08-01 14:55:54
Documents
4
Period of Report
2013-09-17
Effectiveness Date
2013-08-01

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d575295ddef14a.htm | DEF 14A | 415915
2 | GRAPHIC | g575295g10c57.jpg | GRAPHIC | 337453
3 | GRAPHIC | g575295g35d28.jpg | GRAPHIC | 236139
4 | GRAPHIC | g575295g95l79.jpg | GRAPHIC | 7061
| Complete submission text file | 0001193125-13-314871.txt |  | 1217610

Mailing Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22873 | Film No.: 131002352
SIC: 2835 In Vitro & In Vivo Diagnostic Substances